GlassScriptPhysician profile
Daniel A Roquiz
NPI 1295041986
$978.53
in general payments reported to CMS, 2019-2025
11 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.82 · 2022: $132 · 2023: $179 · 2024: $293 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $237.67 | 2021-2025 | Mounjaro, Zepbound |
| Amgen INC. | $166.65 | 2023-2025 | Otezla, Repatha, Repatha |
| Abbott Laboratories | $125.08 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $89.68 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $77.56 | 2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.61 | 2025 | Jardiance |
| Exact Sciences Corporation | $67.98 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $54.64 | 2022-2024 | Ozempic |
| Pfizer INC. | $48.40 | 2023-2025 | |
| Philips North America LLC | $26.16 | 2025 | Extended Holter |
| Phadia US INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Roquiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.